Effects of Long-Term Therapy with the Association of Nisoldipine and a Beta-Blocker on Exercise Tolerance and Coronary Hemodynamics in Patients with Stable Angina: A Comparison with Monotherapy

1987 ◽  
pp. 213-222 ◽  
Author(s):  
M. F. Rousseau ◽  
C. Hanet ◽  
J. P. Desager ◽  
H. Pouleur
1998 ◽  
Vol 3 (4) ◽  
pp. 275-279
Author(s):  
Prakash C. Deedwania ◽  
Robert E. Safford ◽  
Marcus de Wood ◽  
Dennis Costello ◽  
Steven Goldsmith

1990 ◽  
Vol 30 (12) ◽  
pp. 1106-1111 ◽  
Author(s):  
Hillel S. Ribner ◽  
Kiran B. Sagar ◽  
Stephen P. Glasser ◽  
Ann-Ming Hsieh ◽  
Cynthia V. Dills ◽  
...  

1990 ◽  
Vol 10 (2) ◽  
pp. 39-46
Author(s):  
GT Kennedy

Captopril is an effective oral drug that helps break the cycle of CHF. Improvements in symptomatology, functional capacity and exercise tolerance are seen with long-term therapy. Captopril is an important addition to the present drug therapy of CHF.


1997 ◽  
Vol 17 (03) ◽  
pp. 161-162
Author(s):  
Thomas Hyers

SummaryProblems with unfractionated heparin as an antithrombotic have led to the development of new therapeutic agents. Of these, low molecular weight heparin shows great promise and has led to out-patient therapy of DVT/PE in selected patients. Oral anticoagulants remain the choice for long-term therapy. More cost-effective ways to give oral anticoagulants are needed.


2007 ◽  
Vol 40 (05) ◽  
Author(s):  
M Kungel ◽  
A Engelhardt ◽  
T Spevakné-Göröcs ◽  
M Ebrecht ◽  
C Werner ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document